Growing Funding Support Endo Tools Therapeutics has secured approximately $9.7 million in funding through multiple Series D rounds led by White Fund, indicating strong investor confidence and potential for financial growth that could facilitate expansion into new markets or product lines.

US Market Expansion With the launch of U.S. commercial cases for the Endomina system in August 2022, the company is actively expanding its footprint in the United States, opening opportunities to engage with leading healthcare providers and gastroenterology clinics.

Event Presence Participation in prominent industry events like ESGE DAYS 2025 demonstrates the company’s commitment to visibility within the gastroenterology community, providing a platform to showcase innovations and build strategic partnerships.

Niche Industry Focus Operating in the specialized medical device market with a focus on therapeutic tools for gastroenterologists, Endo Tools Therapeutics offers tailored solutions, making it a promising partner for healthcare providers seeking innovative minimally invasive procedures.

Targeted Customer Base Given the company's size and focus, targeting gastroenterology clinics and hospital systems that invest in advanced endoscopic devices presents a clear opportunity to grow sales and establish long-term relationships in a growing medical specialty.